MGP Ingredients (MGPI) Tops Q3 EPS by 11c; Guides Above Views

MGP Ingredients (NASDAQ: MGPI) reported Q3 EPS of $1.07, $0.11 better than the analyst estimate of $0.96. Revenue for the quarter came in at $201.2 million versus the consensus estimate of $190.71 million.

GUIDANCE:

MGP Ingredients sees FY2022 EPS of $4.62-$4.80, versus the consensus of $4.67. MGP Ingredients sees FY2022 revenue of $765-780 million, versus the consensus of $760.72 million.

For earnings history and earnings-related data on MGP Ingredients (MGPI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c